Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies

por Singh RP, Staurenghi G, Pollack A, Adewale A, Walker TM, Sager D, Lehmann R
Publicado 2017

Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy

por Singh R, Alpern L, Jaffe GJ, Lehmann RP, Lim J, Reiser HJ, Sall K, Walters T, Sager D
Publicado 2012